Internal Medicine Doctors in Red Wing, MN Accepting Medicare

9 Internal Medicine doctors found. Showing 1 - 9

Santhi Subramaniam, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Hewitt Blvd, Red Wing, MN 55066 Phone: 651-267-5000

Claire V Thomas, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 701 Hewitt Blvd, Red Wing, MN 55066 Phone: 651-267-5000    Fax: 651-385-3273

Donald L Bruns, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 701 Fairview Blvd, Red Wing, MN 55066 Phone: 651-267-5000

Edward L Ward, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Hewitt Blvd, Red Wing, MN 55066 Phone: 651-267-5000    Fax: 651-267-5930

Jennifer M Radtke, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Hewitt Blvd, Red Wing, MN 55066 Phone: 651-267-5000

Dr. George Edward Jackish, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 28089 Bayview Drive, Red Wing, MN 55066 Phone: 651-388-9437

Thomas M.g. Meyer, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Hewitt Blvd, Red Wing, MN 55066 Phone: 651-267-5000

William David Farrar, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 701 Hewitt Blvd, Red Wing, MN 55066 Phone: 651-267-5000

Jack W Alexander, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 701 Hewitt Blvd, Red Wing, MN 55066 Phone: 651-267-5000

News Archive

‘Love hormone' from insects could be used as drug lead to prevent uterine contractility in preterm labour

In a recent study published in "Scientific Reports", an international team of researchers led by MedUni Vienna report that an oxytocin-like neuropeptide ("inotocin") exhibited a specific pharmacological profile for the human receptors of oxytocin (known as the "love hormone") and vasopressin.

ACCC survey finds multiple threats to growth of cancer programs

At a time of unprecedented advances in the science of cancer, growing complexity in cancer treatments, and ongoing health policy fluctuation, the Association of Community Cancer Centers ninth annual Trending Now in Cancer Care survey reveals how cancer programs across the country are being impacted by pressure from turbulence in multiple sectors: payers, government, and industry.

Negative press: Veterans Support Organization calls on reporters to perform adequate research

Recently there has been considerable negative press about The Veterans Support Organization. The information obtained from both TV News and Print Reporters was flawed.

Avila commences AVL-292 Phase 1 clinical study for B cell cancers and autoimmune diseases

Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs, announced today that it has initiated a phase 1 clinical trial to assess the safety, tolerability and pharmacokinetic profile of AVL-292, a novel, orally available, covalent drug that targets Bruton's tyrosine kinase (Btk). AVL-292 is the first product candidate to enter clinical evaluation from Avila's proprietary covalent drug platform, Avilomics™.

Read more Medical News

› Verified 6 days ago